(NYSE: CBT) Cabot's forecast annual revenue growth rate of 3.22% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 3.24%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.4%.
Cabot's revenue in 2025 is $3,991,000,000.On average, 3 Wall Street analysts forecast CBT's revenue for 2025 to be $222,798,442,152, with the lowest CBT revenue forecast at $219,992,859,492, and the highest CBT revenue forecast at $227,459,158,940. On average, 3 Wall Street analysts forecast CBT's revenue for 2026 to be $230,042,053,933, with the lowest CBT revenue forecast at $228,075,657,304, and the highest CBT revenue forecast at $233,477,744,552.
In 2027, CBT is forecast to generate $238,145,835,463 in revenue, with the lowest revenue forecast at $237,595,324,654 and the highest revenue forecast at $238,574,564,800.